HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 102/4/1658    most recent 00105.2006v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Budgett, D. M. Articles by Malpas, S. C. Search for Related Content PubMed PubMed Citation Articles by Budgett, D. M. Articles by Malpas, S. C.

INNOVATIVE METHODOLOGY

Novel technology for the provision of power to implantable physiological devices

¹Bioengineering Institute and ²Department of Electrical and Computer Engineering and ³Department of Physiology, University of Auckland, Auckland, New Zealand

Submitted 27 January 2006 ; accepted in final form 5 January 2007

We report the development of a novel technology that enables the wireless transmission of sufficient amounts of power to implantable physiological devices. The system involves a primary unit generating the magnetic field and a secondary pickup unit deriving power from the magnetic field and a power conditioner. The inductively coupled system was able to supply a minimum of 20 mW at all locations and pickup orientations across a rat cage, although much higher power of up to 10 W could be achieved. We hypothesized that it would be possible to use this technology to record a high-fidelity ECG signal in a conscious rat. A device was constructed in which power was utilized to recharge a battery contained within a telemetry device recording ECG signal sampled at 2,000 Hz in conscious rats (200–350 g) living in their home cage. Attributes of the ECG signal (QT, QRS, and PR interval) could be obtained with a high degree of accuracy (<1 ms). ECG and heart rate changes in response to treatment with the beta blocker propranolol and the proarrhythmic alkaloid aconitine were measured. Transmitters were implanted for up to 4 mo, and the characteristic circadian variation in heart rate was recorded. Such technology allows potentially lifetime monitoring without the need for implant refurbishment. The ability to provide suitable power levels to implanted devices without concern to the orientation of the device and without causing heating provides the basis for the development of new devices to record or influence physiological signals in animals or humans over significantly longer time periods than can currently be accommodated.

telemetry; inductive power; battery; biopotential; electrocardiogram

This article has been cited by other articles:

				S.-J. Guild, C. J. Barrett, F. D. McBryde, B. N. Van Vliet, and S. C. Malpas Sampling of cardiovascular data; how often and how much? Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2008; 295(2): R510 - R515. [Abstract] [Full Text] [PDF]